Collection of samples from patients with rheumatic diseases
Official title: Rheumatologic Biobank for Clinical and Basic Research: Isolation, Extraction and Storage of Protein, DNA and RNA Extracted From Tissues of Patients With Rheumatoid Diseases
Run by Meir Medical Center · NCT03473912 · Data updated 2026-11-12
This study is collecting samples from people with rheumatic diseases to help researchers learn more about these conditions and improve treatments in the future.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 120 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Meir Medical Center Academic / other |
| Locations | 1 site (Kfar Saba) |
| Status | Recruiting |
| Started | April 16, 2018 |
| Main results expected | November 2037 |
| Study ends | November 2037 |
| Registry record updated | March 11, 2019 |
| Trial ID | NCT03473912 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years of age who have a diagnosed rheumatic condition and are willing to provide informed consent.
✕Probably not a fit
Patients who do not have a rheumatic condition or are under 18 years of age will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to create a biobank by collecting serum, synovial fluid, and skin biopsies from patients diagnosed with various rheumatic diseases. The samples will be utilized for both clinical and basic research to better understand the genetic and protein profiles associated with these conditions. The goal is to enhance knowledge about disease progression, response to therapy, and the underlying factors contributing to these autoimmune diseases. The biobank will serve as a valuable resource for future studies aimed at advancing personalized medicine in rheumatology.
Why it matters
Potential benefit: If successful, this biobank could lead to improved understanding and treatment of rheumatic diseases, ultimately benefiting patients through more personalized therapeutic approaches.
How similar studies have gone: Other studies utilizing biobanks for rheumatic diseases have shown promise in advancing research, indicating that this approach is both valuable and tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * above 18 years of age * willing to sign informed consent * have a rheumatoid condition Exclusion Criteria: \-
Where it's running
-
Meir Medical Center
Kfar Saba, Israel Recruiting
Study contacts
- Principal investigator: Yair Levy, Prof. — Meir Medical Center
- Study coordinator: Yair Levy, Prof.
- Email: levy.yair@clalit.org.il
- Phone: 972-9-7471524
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pain patterns in rheumatic diseases: see if pain works differently in patients and healthy people
This observational study tests how pain is experienced and measured in people with rheumatic diseases compared with healthy volunteers.
-
Registry and biorepository for rheumatic diseases
This study is collecting samples and health information from adults with rheumatic diseases at Yale clinics to help researchers learn more about these conditions and improve future treatments.
-
First-in-human test of CND319 in healthy people and people with rheumatic diseases
This early study tests whether CND319 is safe and tolerable and whether it shows any signs of activity in healthy adults and in people with rheumatoid arthritis or Sjogren's syndrome.
-
Test of HBM7020 in healthy adults and adults with autoimmune diseases
This first-in-human study tests whether HBM7020 is safe and how it acts in the body for people with autoimmune diseases like RA, SLE, Sjögren's, and SSc compared with healthy volunteers.
-
Anti-CD19/BCMA universal CAR-T cell therapy for refractory autoimmune diseases
This will try anti-CD19/BCMA universal CAR-T cell therapy in adults with refractory rheumatoid arthritis, dermatomyositis, systemic lupus, or systemic sclerosis to see if it is safe and can control their disease.
-
Immun4Cure Cohort of Autoimmune Diseases
A long-term, 500-person database and biobank is being built to study autoimmune diseases like RA, SLE, and scleroderma, plus healthy adults, using deep profiling and regular follow-ups over five years.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.